Gemigliptin added to ongoing metformin therapy provides sustained glycaemic control over 52 weeks and was well tolerated in patients with type 2 diabetesE. J. Rhee,K. W. Min, H. C. Jang, C. H. Chung, I. S. Nam-Goong, H. Y. Bae,S. H. Baik, V. K. Shivane,A. R. Sosale,M. Dharmalingam,P. Gandhi,S. K. Gupta, J. Y. Ahn, K. S. Bang,M. K. LeeDIABETOLOGIA（2013）引用 0|浏览5暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
